Notable Thursday Option Activity: AVBP, GRAL, APPN

Grail Inc (GRAL) saw 3,308 options contracts trade today (≈330,800 underlying shares), equal to about 47.7% of its one‑month average daily volume of 693,495 shares; activity was concentrated in the $130 call expiring Feb 20, 2026 (534 contracts, ≈53,400 shares). Appian Corp (APPN) recorded 3,759 contracts (≈375,900 underlying shares), roughly 47% of its one‑month average daily volume of 800,155 shares, with heavy flow in the $30 put expiring Feb 20, 2026 (3,489 contracts, ≈348,900 shares). The concentrated strike/expiration activity suggests notable directional or hedging positioning in both names but contains no company fundamental news.

Analysis

Market structure: The flow (options volume ≈47% of ADTV for both GRAL and APPN) signals concentrated, one-sided positioning: large buyer interest in Feb 20, 2026 $130 calls on GRAL (≈53.4k shares) and $30 puts on APPN (≈348.9k shares). Immediate winners are options sellers/market-makers collecting premium and prime liquidity providers; losers are passive holders if delta-hedging forces accentuate short-term moves and widens spreads. This concentrated flow raises single-stock implied vol and increases transaction costs for large block trades; expect local gamma-driven price pressure into re-hedging windows.

Risk assessment: Tail risks include company-level catalysts (M&A, FDA/regulatory headlines for GRAL; contract losses or downtime for APPN) and dealer de-risking that can cascade into temporary liquidity shocks. In the next 1–14 days expect heightened realized vol and potential 5–20% moves intraday; over 1–12 months fundamentals reassert, so options flow is a volatility not valuation signal. Hidden dependency: dealers’ delta-hedging may force directional stock trades; if large positions are protective hedges rather than directional bets, implied vol can collapse post-catalyst.

Trade implications: For tactical exposure prefer defined-risk option spreads to capture directional skew while limiting capital: example — buy GRAL Feb 2026 $130/$170 call vertical sized to 1% portfolio risk; buy APPN Feb 2026 $30/$20 put vertical sized 0.75–1% as bearish hedge. Consider a relative pair (long GRAL call spread, short APPN equity or funded put spread) to isolate idiosyncratic flow risk; trim at +30–50% realized P&L or cut at -60% of premium. Monitor IV; if 30‑day IV >50% vs 180‑day <30% consider mean-reversion premium selling (calendar/iron condor) with strict stops.

Contrarian angles: The headline flow can be misread — heavy put buying on APPN may be protective (existing long EQ holders) not new naked bearish speculation; similarly GRAL call demand could be hedging around M&A rumors. Reaction may be overdone in IV terms: if no fundamental catalyst emerges in 30–90 days expect IV compression 20–40%, creating opportunities to sell premium. Beware unintended consequences: aggressive selling of premium into a thin market can trigger gamma squeezes that inflict >20% slippage vs expected P&L.

Key Decisions for Investors

• Establish a defined-risk bullish position in GRAL: buy the Feb 20, 2026 $130/$170 call vertical sized to risk 1% of portfolio (max loss = premium paid). Exit on +40% premium gain or cut at -60% loss; reassess if GRAL spot moves >20% before event-driven news.
• Establish a bearish hedge in APPN: buy the Feb 20, 2026 $30/$20 put vertical sized to 0.75–1% portfolio risk. Target +40% profit or close if APPN IV drops >30% or stock rallies >15% without fundamental change.